Thomas Gad, See remarks at Y-mAbs Therapeutics, Inc. (YMAB), sold 237,268 shares at $7.90 ($1.8M) on 2022-02-03, disclosed to the SEC on 2022-02-07.
Open-market sale of $1.8M YMAB by See remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.90 | 35,060 | $277K | 15.1% |
| 2 | $7.70 | 101,104 | $779K | 42.4% |
| 3 | $7.70 | 101,104 | $779K | 42.4% |
| Total | $7.73 avg | 237,268 | $1.8M | 100% |
| Filing → |
| YMAB | SELL | 2024-06-11 | $841K | — | Filing → |
| YMAB | SELL | 2024-05-23 | $396K | — | Filing → |
| YMAB | SELL | 2024-03-07 | $128K | — | Filing → |